Philip Johnson, MD
Orthopaedic Surgery · Little Rock, ARNPI 1245222959
Payments from drug & device makers
Across 81 payments — averaging $28.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$451
- DJO, LLC$441
- Amgen$264
- Zimmer Biomet$210
- Radius Health, Inc.$183
- Heron Therapeutics, Inc.$129
- plus $632 from 19 others
What the payments were for
- Speaking & faculty fees$211%
- Food & beverage$2,28999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $451 |
| DJO, LLC | 19 | $441 |
| Amgen(2 entities) | 17 | $264 |
| Zimmer Biomet | 2 | $210 |
| Radius Health, Inc. | 7 | $183 |
| Heron Therapeutics, Inc. | 3 | $129 |
| Medical Device Business Services, Inc. | 1 | $89 |
| Vertex | 4 | $79 |
| Pacira Therapeutics, Inc. | 2 | $66 |
| Polynovo North America LLC | 2 | $47 |
| Misonix Inc | 1 | $42 |
| Baudax Bio Inc. | 2 | $40 |
| Bioventus LLC | 1 | $38 |
| Astellas Pharma US Inc | 1 | $25 |
| Innovation Technologies Inc | 1 | $24 |
| KCI USA, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Kerecis Limited | 1 | $21 |
| Solventum Corporation | 1 | $19 |
| Axogen | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Heraeus Medical, LLC. | 3 | $17 |
| Sanara Medtech Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,310 in reported general payments places this provider in the 45th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 15 | $1,094 |
| Diclofenac Sodium | 27 | $1,024 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $760 |
| Celecoxib | 19 | $414 |
| Meloxicam | 50 | $111 |
| Cephalexin | 14 | $100 |
| Cyclobenzaprine Hcl | 13 | $93 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $92 |
| Tramadol Hcl | 18 | $77 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Little Rock
- Benjamin StronachLittle Rock$2.7M
- Charles BarnesLittle Rock$2.5M
- Jay LipkeLittle Rock$498K
- Kenneth MartinLittle Rock$332K
- David BumpassLittle Rock$246K
- Lawrence O'MalleyLittle Rock$151K
- Jason SmithLittle Rock$102K
- Justin RabinowitzLittle Rock$85K
- Richard McCarthyLittle Rock$75K
- Chelsea MathewsLittle Rock$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.